Trials / Conditions / Stage IVA Bladder Cancer AJCC v8

Stage IVA Bladder Cancer AJCC v8

7 registered clinical trials studyying Stage IVA Bladder Cancer AJCC v8.

Status	Trial	Sponsor	Phase
Withdrawn	Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer N NCT05564416	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	ARID1A and/or KDM6A Mutation and CXCL13 Expression NCT04953104	M.D. Anderson Cancer Center	Phase 2
Terminated	Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progress NCT04902040	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Completed	Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial C NCT03513952	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small NCT03582475	Jonsson Comprehensive Cancer Center	Phase 1
Active Not Recruiting	Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Loca NCT03601455	Jonsson Comprehensive Cancer Center	Phase 2